One Health Group transforms financial outlook with two five-year NHS contracts

One Health Group
[shareaholic app="share_buttons" id_name="post_below_content"]

One Health Group PLC (AQSE:OHGR), the independent provider of free high quality NHS care for patients referred for treatment in Orthopaedics, Spine, General Surgery and Gynaecology, has announced that two of the largest NHS commissioners with which it works have renewed their contracts. It is expected that these new agreements will run for five years rather than twelve months, which has been the case previously, and will cover approximately 4,000 new patients and 2,000 surgical procedures per year.

The two contracts are with Lincolnshire Integrated Care Board (ICB) and South Yorkshire ICB who also act as One Health’s lead commissioner for Derby and Derbyshire and West Yorkshire ICB’s. Under these agreements, One Health will continue to provide free care to NHS patients over a longer term in Doncaster, Barnsley, Rotherham, Sheffield, Wakefield, Kirklees, Leeds, Bradford, Calderdale, Derby and Derbyshire and most of Lincolnshire. One Health has worked with the majority of these NHS commissioners for over 10 years.

Prior to these agreements being established, One Health operated under multiple, individual 12-month Clinical Commissioning Group contracts with each one being renewed every April. Following the establishment of ICB’s, and the abolition of Clinical Commissioning Groups in July 2022, the annual contracts continued, but incorporated wider regions that were previously covered by individual CCG contracts.

Under the new contracts, rather than conducting a ‘mini tender’ process across multiple regions every year, One Health will provide updated policies and supporting documentation as well as anticipated activity levels for the following year by region. As pricing will continue to be set by the ‘National NHS Tariff’ there is no requirement for any financial negotiations. This means the amount of time and effort spent administering renewals by both the NHS and One Health, will be significantly reduced.

One Health will be publishing a trading update for the group for the year to 31 March 2024 on Monday 29 April 2024.

Adam Binns – CEO of One Health Group said:

“These longer-term commitments are a clear indication of the value we deliver to the NHS’ infrastructure and also demonstrate the vital role we play in its supply chain. Most importantly, having this certainty in place will allow us to focus even more closely on activities that make a difference to the lives of patients as we will have the confidence to consider new investments in facilities and additional support services at a time when central government public funding is under pressure.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
One Health Group plc (AQSE:OHGR) CEO Adam Binns discusses key drivers of revenue growth, NHS tariffs, and investment plans amid rising patient demand.
One Health Group CEO Adam Binns discusses H1 2024 revenue growth, NHS collaboration, and expansion plans, highlighting strategic healthcare innovations.
Explore how UK-listed companies like Diversified Energy and Dekel Agri-Vision are leading on sustainable innovation in energy production and agriculture.
Discover top-performing stocks across health, energy, finance, and telecom with insights from leading analysts to make informed investment decisions.
Panmure Liberum highlights One Health Group (AQSE:OHGR) as a key player in the UK's healthcare sector, focusing on NHS-funded surgeries in underserved regions.
One Health Group (AQSE:OHGR) reports over 20% H1 2025 revenue growth, driven by an increase in NHS patient numbers and expanded surgical capacity.

Search

Search